C O M M U N I C A T I O N S
analogues of type 4. High activity on the more sterically encum-
bered ortho-substituted and 1-naphthyl derivatives is particularly
noteworthy.
nitrilases, this process was operated on a 1.0 g scale (240 mM 7,
30 mg enzyme, 22 °C, pH 7) and after 22 h, (R)-8 was isolated in
98% yield and 95% ee. Interestingly, the same screening program
also identified 22 nitrilases that afford the opposite enantiomer (S)-8
with 90-98% ee. Thus, our extensive screen of biodiversity has
uncovered enzymes that provide ready access to either enantiomer
of the intermediate 8 with high enantioselectivities. Our discovery
of the first enzymes that furnish (R)-8 underscores the advantage
of having access to a large and diverse library of nitrilases.
By plumbing our environmental genomic libraries created from
uncultured DNA, we have discovered a large array of novel
nitrilases. This study has revealed nitrilases that furnish mandelic
and aryllactic acid derivatives, as well as either enantiomer of
4-cyano-3-hydroxybutyric acid in high yield and enantiomeric
excess. A more detailed survey of substrate scope associated with
our nitrilase library is underway and will be reported in due course.
We next examined the preparation of aryllactic acid derivatives
6 through hydrolysis of the corresponding cyanohydrins 5. Phenyl-
lactic acid and derivatives serve as versatile building blocks for
the preparation of numerous biologically active compounds.11 Upon
screening our nitrilase library against the parent cyanohydrin 5a
(Ar ) phenyl), we found several enzymes that provided 6a with
high enantiomeric excess. One enzyme, nitrilase II, was further
characterized. A reaction using 2 mg of nitrilase (0.016 mg/mL
nitrilase II) allowed complete transformation of 1.0 g of 5a (50
mM) within 6 h and afforded (S)-phenyllactic acid (6a), which was
isolated in high yield (0.95 g, 84%) and with 96% ee. The highest
enantioselectivity previously reported for biocatalytic conversion
of 5 to 6 was 75% ee achieved through a whole cell transformation
using a Pseudomonas strain.12
Acknowledgment. We thank B. Morgan, J. McQuaid, K.
Keegan, I. Saliba, and N. Farid for assisting with preliminary
enzyme screening, and P. Kretz, E. Chi, A. Milan, M. Miller, D.
Wyborski, and I. Andruszkiewicz for enzyme discovery. T. Rich-
ardson, M. Podar, and L. Waters are gratefully acknowledged for
bioinformatic analysis. We thank D. Baptista, J. Gemsch, and L.
Bibbs for sequencing, R. Melkus and X. Tan for subcloning, P.
Chen for analytical assistance, and A. Flordeliza, D. DiMasi and
A. Vasavada for expression. We thank K. Avery (Dow) for
discussion on substrate synthesis. Special thanks goes to Mark
Madden for providing initial inspiration for the nitrilase program,
and to Jay Short for valuable discussions and support.
Table 2. Nitrilase II-Catalyzed Production of Aryllactic Acid
Derivatives and Analogues 6 under DKR Conditionsa
c
entry
Ar in 6
specific activityb
TOF
%eed
1
2
3
4
5
6
7
8
9
C6H5
25
160
121
155
21
22
64
10.5
11.6
3.4
2.3
16
100
76
97
13
14
40
6.6
96
95
95
91
95
99
96
99
97
96
97
2-Me-C6H5
2-Br-C6H5
2-F-C6H5
3-Me-C6H5
3-F-C6H5
1-naphthyl
2-pyridyl
3-pyridyl
2-thienyl
Supporting Information Available: Materials and methods and
amino acid sequence (PDF). This material is available free of charge
7.2
2.1
1.4
10
11
References
3-thienyl
(1) Address: Dow Chemical Co., Midland, MI.
a Reaction conditions as in Table 1, except 0.016 mg/mL nitrilase
was used. Full conversion to 6 was observed within 6 h. b-d See Table 1.
The absolute configuration was determined to be (S) for phenyllactic acid
and entries 2-11 were assigned (S) based upon identical chiral HPLC
peak elution order.
(2) Wong, C.-H.; Whitesides, G. M. Enzymes in Synthetic Organic Chemistry,
2nd ed.; Pergamon: New York, 1994. (b) Drauz, K., Waldmann, H.,
Roberts, S. M., Eds. Enzyme Catalysis in Organic Synthesis; VCH:
Weinheim, Germany, 2002.
(3) (a) Kobayashi, M.; Shimizu, S. FEMS Microbiol. Lett. 1994, 120, 217.
(b) Bunch, A. W. In Biotechnology; Rehm, H.-J., Reed, G., Puhler, A.,
Stadler, P., Eds.; Wiley-VCH: Weinheim, Germany, 1998; Vol. 8a,
Chapter 6, pp 277-324. (c) Wieser, M.; Nagasawa, T. In StereoselectiVe
Biocatalysis; Patel, R. N., Ed.; Marcel Dekker: New York, 2000; Chapter
17, pp 461-486.
(4) (a) Harper, D. B. Int. J. Biochem. 1985, 17, 677. (b) Levy-Schil, S.;
Soubrier, F.; Crutz-Le Coq, A. M.; Faucher, D.; Crouzet, J.; Petre, D.
Gene 1995, 161, 15. (c) Yu, F. U.S. Patent 5,872,000, 1999. (d) Ress-
Loschke, M.; Friedrich, T.; Hauer, B.; Mattes, R.; Engels, D. PCT Appl.
WO 00/23577, April 2000.
(5) For a description of these methods, see: (a) Short, J. M. Nat. Biotechnol.
1997, 15, 1322. (b) Handelsman, J.; Rondon, M. J.; Brady, S. F.; Clardy,
J.; Goodman, R. M. Chem. Biol. 1998, 5, R245. (c) Henne, A.; Daniel,
R.; Schmitz, R. A.; Gottschalk, G. Appl. EnViron. Microbiol. 1999, 65,
3901.
Ortho and meta substituents appear to be tolerated well by
nitrilase II, with ortho substituted derivatives surprisingly being
converted with higher rates relative to the parent substrate 5a. Novel
heteroaromatic derivatives, such as 2-pyridyl-, 3-pyridyl, 2-thienyl-,
and 3-thienyllactic acids, were prepared with high conversions and
enantioselectivities (Table 2, entries 8-11). Unexpectedly, para
substituents greatly lowered the rates of these reactions, with full
conversion taking over two weeks under these conditions (data not
shown).
The final transformation that we examined was desymmetrization
of the readily available prochiral substrate 3-hydroxyglutaronitrile
(7)13 to afford hydroxy acid (R)-8 which, once esterified to (R)-9,
is an intermediate used in the manufacture of the cholesterol-
lowering drug Lipitor. Previously reported attempts to use enzymes
for this process were unsuccessful, and 8 was produced with low
selectivity (highest: 22% ee) and the undesired (S)-configuration.14
(6) (a) Robertson, D. E.; Mathur, E. J.; Swanson, R. V.; Marrs, B. L.; Short,
J. M. SIM News 1996, 46, 3. (b) Short, J. M. U.S. Patent 5,958,672, 1999.
(c) Short, J. M. U.S. Patent 6,030,779, 2000.
(7) For a concise description, see Supporting Information section.
(8) Pace, H.; Brenner, C. Genome Biol. 2001, 2, 0001.1-0001.9.
(9) Inagaki, M.; Hiratake, J.; Nishioka, T.; Oda, J. J. Org. Chem. 1992, 57,
5643. (b) van Eikeren, P. U.S. Patent 5,241,087, 1993.
(10) (a) Yamamoto, K.; Oishi, K.; Fujimatsu, I.; Komatsu, K. Appl. EnViron.
Microbiol. 1991, 57, 3028. (b) Endo, T.; Tamura, K. U.S. Patent 5,296,373,
March, 1994.
(11) Coppola, G. M.; Schuster, H. F. Chiral R-Hydroxy Acids in Enantio-
selectiVe Synthesis; Wiley-VCH: Weinheim, Germany, 1997.
(12) Hashimoto, Y.; Kobayashi, E.; Endo, T.; Nishiyama, M.; Horinouchi, S.
Biosci. Biotechnol. Biochem. 1996, 60, 1279.
(13) Johnson, F.; Panella, J. P.; Carlson, A. A. J. Org. Chem. 1962, 27, 2241.
(14) (a) Crosby, J. A.; Parratt, J. S.; Turner, N. J. Tetrahedron: Asymmetry
1992, 3, 1547. (b) Beard, T.; Cohen, M. A.; Parratt, J. S.; Turner, N. J.
Tetrahedron: Asymmetry 1993, 4, 1085. (c) Kakeya, H.; Sakai, N.; Sano,
A.; Yokoyama, M.; Sugai, T.; Ohta, H. Chem. Lett. 1991, 1823.
We screened our nitrilase library and have discovered four unique
enzymes that provided the required product (R)-8 with high
conversion (>95%) and >90% ee. Using one of the (R)-specific
JA0259842
9
J. AM. CHEM. SOC. VOL. 124, NO. 31, 2002 9025